Stock listing
RCUS Stock Price, News, Filings & Events — Arcus Biosciences, Inc.
Selected listing: RCUS · NYSE · USD · US
This page tracks Arcus Biosciences, Inc.'s RCUS:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RCUS:NYSE. RCUS:NYSE is the stock-level entry point for investors researching Arcus Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $3.44 billion, Arcus is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.
- Ticker
- RCUS:NYSE
- Asset type
- Stock
- Market cap
- $3.72B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
Arcus Biosciences, Inc. RCUS:NYSE stock context
This page tracks Arcus Biosciences, Inc.'s RCUS:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RCUS:NYSE. RCUS:NYSE is the stock-level entry point for investors researching Arcus Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $3.44 billion, Arcus is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.
Latest news from Arcus Biosciences, Inc.
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advance...
July 22, 2026
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kid...
July 22, 2026
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
July 21, 2026
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bis...
June 3, 2026
Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
Arcus Biosciences, Inc. earnings calls
Arcus Biosciences, Inc. (RCUS) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Arcus Biosciences, Inc. (RCUS) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call
November 6, 2024 · Replay with transcript and chapters
Arcus Biosciences, Inc. (RCUS) Q2 2024 Earnings Call
August 8, 2024 · Replay with transcript and chapters
Research Arcus Biosciences, Inc.
Arcus Biosciences, Inc. investor report
Review AI stock analysis and investor report context for RCUS:NYSE.
Arcus Biosciences, Inc. company profile
View the public company page for Arcus Biosciences, Inc. on 6ix.
Arcus Biosciences, Inc. news
Read company news and market updates connected to Arcus Biosciences, Inc..
Arcus Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Arcus Biosciences, Inc..